EVENTIDE ASSET MANAGEMENT, LLC

Holdings History for Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

Symbol: MIRM on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 2,093,582 shares
Security Ownership %: 4.1%

Shares, Excluding Options vs Price

Value, Excluding Options

Eventide Asset Management, LLC ownership in Mirum Pharmaceuticals, Inc. Common Stock (MIRM)

13 Feb 2026 - Eventide Asset Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,093,582 shares of Mirum Pharmaceuticals, Inc. Common Stock (MIRM). This represents 4.1% ownership of the company. In their previous filing dated 14 Feb 2025, EVENTIDE ASSET MANAGEMENT, LLC had reported owning 2,606,938 shares, indicating a decrease of +20%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Eventide Asset Management, LLC	4.1%	-27%	$165,372,042	2,093,582	-513,356	-20%	$78.99	13G/A	31 Dec 2025	13 Feb 2026, 13:09
Eventide Asset Management, LLC	5.4%		$107,692,609	2,606,938			$41.31	13G/A	31 Dec 2024	14 Feb 2025, 12:06

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.6%	-0.53%	$165,370,112	2,093,582	-428,981	-17%	$78.99	Q4 2025
30 Sep 2025	3%	-0.14%	$184,923,401	2,522,563	-114,922	-4.4%	$73.31	Q3 2025
30 Jun 2025	2.4%	+0.1%	$134,224,124	2,637,485	+110,485	+4.4%	$50.89	Q2 2025
31 Mar 2025	2.3%	-0.07%	$113,851,178	2,527,000	-79,938		$45.05	Q1 2025
31 Dec 2024	2%	-0.63%	$107,795,242	2,606,938	-838,425	-24%	$41.35	Q4 2024
30 Sep 2024	2.3%	-0.11%	$134,369,157	3,445,363	-169,457	-4.7%	$39.00	Q3 2024
30 Jun 2024	2.1%	+0.17%	$123,590,696	3,614,820	+314,420	+9.5%	$34.19	Q2 2024
31 Mar 2024	1.3%	+0.25%	$82,906,048	3,300,400	+636,751	+24%	$25.12	Q1 2024
31 Dec 2023	1.3%	-0.62%	$78,630,919	2,663,649	-1,294,930	-33%	$29.52	Q4 2023
30 Sep 2023	2.3%	+0.28%	$125,091,097	3,958,579	+499,378	+14%	$31.60	Q3 2023
30 Jun 2023	1.5%	+0.61%	$89,489,530	3,459,201	+1,400,000	+68%	$25.87	Q2 2023
31 Mar 2023	0.91%	+0%	$49,462,008	2,059,201	+2,201	+0.11%	$24.02	Q1 2023
31 Dec 2022	0.79%	+0.3%	$40,111,500	2,057,000	+782,000	+61%	$19.50	Q4 2022
30 Sep 2022	0.53%	+0.53%	$26,788,000	1,275,000	+1,275,000	NEW	$21.01	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.